VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Verve Therapeutics, Inc. (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”) of the important October 28, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg So what: […]